newsfilter
← Latest News
PR Newswire·

MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government Funded $3 Million Clinical Trial

Clinical validation of MYND Diagnostics' proprietary biomarkers in evaluating the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression VANCOUVER, BC, Feb. 8, 2022 /PRNewswire/ - MYND Diagnostics Inc., a wholly-owned subsidi